Company intelligence / Profile preview

Yongnong Biosciences

Hangzhou, Zhejiang, China

Ownership: Private
Employees: ~2200
Development stage: Other

Overview

Yongnong is the world’s leading producer of generic glufosinate-ammonium, with the first global bio-manufacturing line for glufosinate-p and strong market leadership in herbicide technical innovation and scale. The company is commercial-stage, with global registrations and partnerships.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small molecule
Industry: Agriculture & AgTech

Partnerships

ADAMASyngenta

Beyond the preview

Go deeper on Yongnong Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yongnong Biosciences.

Explore the full profile